Keyphrases
Heart Failure Hospitalization
100%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
100%
Real-world Population
100%
Heart Failure
25%
Confidence Interval
16%
Serum Albumin Level
16%
Odds Ratio
16%
Low Serum Albumin
16%
High Dose
16%
Inhibitor Therapy
16%
Cardiovascular Mortality
8%
Clinical Factors
8%
Risk Factors
8%
Consecutive Patients
8%
High Incidence
8%
Baseline Characteristics
8%
Patients with Heart Failure
8%
Hospitalization
8%
Loop Diuretics
8%
Furosemide
8%
Medicine and Dentistry
Cotransporter
100%
Congestive Heart Failure
100%
Sodium Glucose Cotransporter 2 Inhibitor
100%
Serum Albumin
18%
Drug Megadose
18%
Odds Ratio
18%
Cardiovascular System
9%
Recurrent Disease
9%
Furosemide
9%
Loop Diuretic Agent
9%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Cotransporter
100%
Sodium Glucose Cotransporter 2 Inhibitor
100%
Serum Albumin
18%
Recurrent Disease
9%
Loop Diuretic Agent
9%
Furosemide
9%
Neuroscience
Cotransporter
100%
Serum Albumin
18%
Loop Diuretic
9%
Furosemide
9%
Immunology and Microbiology
Cotransporter
100%
Albumin Level
18%
Drug Megadose
18%